v3.26.1
SEGMENT REPORTING (Details)
12 Months Ended
Sep. 30, 2025
USD ($)
segment
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
SEGMENT REPORTING      
Number of operating segments | segment 3    
Number of reportable segments | segment 3    
Revenue $ 37,919,425 $ 25,097,951 $ 46,471,478
Cost of revenue 31,607,966 20,983,196 44,719,984
Gross Profit 6,311,459 4,114,755 1,751,494
Depreciation and amortization 1,463,190 1,237,230 1,143,064
Capital expenditures 2,186,904 3,931,471 3,714,089
International markets      
SEGMENT REPORTING      
Revenue 0    
Diversified Pharmaceutical and Allied Products      
SEGMENT REPORTING      
Revenue 23,591,893 25,097,951 46,471,478
Cost of revenue 20,896,423 20,983,196 44,719,984
Gross Profit 2,695,470 4,114,755 1,751,494
Depreciation and amortization 1,393,233 1,237,230 1,143,064
Capital expenditures 2,030,607 $ 3,931,471 $ 3,714,089
AI Solutions      
SEGMENT REPORTING      
Revenue 3,362,732    
Cost of revenue 1,868,683    
Gross Profit 1,494,049    
Depreciation and amortization 66,913    
Capital expenditures 141,390    
Insurance Business      
SEGMENT REPORTING      
Revenue 10,964,800    
Cost of revenue 8,842,860    
Gross Profit 2,121,940    
Depreciation and amortization 3,044    
Capital expenditures $ 14,907